Drugs / H5.001CBCFTR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004287 | Nov 1995 → ? | cystic fibrosis | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H5.001CBCFTR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004287 ↗ |
| Route | Other | “is administered endobronchially” NCT00004287 ↗ |
| Target | CFTR | “H5.001CBCFTR, an adenovirus vector containing the cystic fibrosis transmembrane conductance regulator gene, is administered endobronchially.” NCT00004287 ↗ |